Literature DB >> 10751723

Analysis of chromosomal aberration frequencies in the peripheral blood lymphocytes of smokers exposed to uranyl compounds.

P A Prabhavathi1, S K Fatima, M S Rao, P P Reddy.   

Abstract

One hundred fifteen smokers working in a nuclear fuel manufacturing facility were analysed for various types of chromosomal aberrations. They experienced exposure for a period of 1-25 years. Their age ranges from 23 to 52 years. A total of 94 smokers and 118 non-smokers who were not exposed to uranyl compounds or to any other known mutagens and belong to the same age group formed the control subjects. The results showed that there is a significant increase in the frequency of chromosomal aberrations in the exposed smokers when compared to the control smokers. In the control group, the smokers showed a high frequency of chromosomal aberrations when compared to non-smokers suggesting clastogenic effect of smoking. Chromosomal aberrations observed in the exposed smokers could be due to the cumulative effect of both smoking and exposure to uranyl compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751723     DOI: 10.1016/s1383-5718(99)00236-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Assessment of DNA damage using chromosomal aberrations assay in lymphocytes of waterpipe smokers.

Authors:  Enas S Alsatari; Mohammad Azab; Omar F Khabour; Karem H Alzoubi; May F Sadiq
Journal:  Int J Occup Med Environ Health       Date:  2012-06-22       Impact factor: 1.843

2.  Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium.

Authors:  Karen L Cooper; Erica J Dashner; Ranalda Tsosie; Young Mi Cho; Johnnye Lewis; Laurie G Hudson
Journal:  Toxicol Appl Pharmacol       Date:  2015-11-25       Impact factor: 4.219

3.  Uranium concentration in blood samples of Southern Iraqi leukemia patients using CR-39 track detector.

Authors:  Anees A Al-Hamzawi; M S Jaafar; Nada F Tawfiq
Journal:  J Radioanal Nucl Chem       Date:  2013-11-05       Impact factor: 1.371

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.